THE ADDITION OF HIGH-DOSE INTRAVENOUSBOLUS OF METHYL-PREDNISOLONE INCREASES THE EARLY CLINICAL RESPONSE TO ORAL CORTICOSTEROIDS IN MODERATELY ACTIVE ULCERATIVE COLITIS. PRELIMINARY RESULTS OF A PROSPECTIVE, CONTROLLED, MULTICENTRE, RANDOMISED, OPEN-LABEL

Jordina Llaó Guárdia  ¹     Miriam Mañosa Ciria  ²     Eduardo Martín Arranz  ³     Yamile Zabana  ⁴     Mercè Navarro-Llavat  ⁵     Esther García-Planella  ⁶     David Busquets Casals  ⁷     Juan-Ramón Pineda  ⁸     David Monfort Miquel  ⁹     Ana Gutiérrez-Casbas  ¹⁰     Francisco Javier Garcia-Alonso  ¹¹     Luis Menchén  ¹²     Abert Villoria  ¹³     Eugeni Domenech Morral    
¹ Althaia, Xarxa Assistencial Universitària de Manresa, Manresa, Spain
² Germans Trias i Pujol University Hospital, CIBEREHD, Badalona, Spain
³ Hospital Universitario La Paz, Madrid, Spain
⁴ Hospital Universitari Mútua Terrassa, CIBEREHD, Terrassa, Spain
⁵ Hospital de Sant Joan Despí Moisès Broggi, Sant Joan Despí, Spain
⁶ Hospital del la Santa Creu i Sant Pau, Barcelona, Spain
⁷ H. de Girona Dr. Josep Trueta, Girona, Spain
⁸ Xerencia Xestión Integrada de Vigo, Vigo, Spain
⁹ Hospital Consorci de Terrassa, Terrassa, Spain
¹⁰ Hospital General Universitario Alicante, CIBEREHD, Alicante, Spain
¹¹ Hospital Universitario Río Hortega, Valladolid, Spain
¹² Hospital Gregorio Marañón, CIBEREHD, Madrid, Spain
¹³ Hospital Parc Taulí, CIBEREHD, Sabadell, Spain

Session
Investigator studies in IBD I (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)